A Bite Force Study Comparing Two New Test Adhesives With Currently Marketed Denture Adhesive

Exclusion Criteria

• •A woman who is known to be pregnant or who is intending to become pregnant (self reported) over the duration of the study.
• •A woman who is breast-feeding.
• •Implanted with a cardiac pacemaker.
• •Daily doses of medication that might interfere with the ability to perform the study according to protocol (as determined by the Investigator).
• •Taking or have taken a bisphosphonate drug for treatment of osteoporosis.
• •A serious chronic disease requiring hospitalization.
• •Any condition not previously mentioned that in the Investigator's opinion may impair the study evaluation.
• •Known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients.
• •Any clinically significant or relevant oral abnormality (e.g. temporomandibular joint \[TMJ\] problems) that, in the opinion of the investigator, could affect the participant's participation in the study.
• •Any participant clinically identified as having an incisal bite relation which could affect the bite force measurements.
• •Severe dry mouth that may affect denture retention in the opinion of the Investigator.
• •OST examination findings such as stomatitis, open sores, lesions, redness or swelling that, in the opinion of the investigator, could affect the participant's participation in the study.
• •Participation in another clinical study (including cosmetic studies) or receipt of an investigational drug within 30 days of the screening visit.
• •Previous participation in this study.
• •Recent history (within the last year) of alcohol or other substance abuse.
• •A participant who is unwilling to refrain from smoking, including e-cigarettes and the use of chewing tobacco or other tobacco products for the duration of screening and each treatment day (12-14 hours).
• •An employee of the sponsor or the study site or members of their immediate family.